Tirzepatide 5mg (also known as Mounjaro)– Research Peptide
For Laboratory Research Use Only. Not for Human Consumption.
Tirzepatide is a cutting-edge investigational peptide that acts as a dual GIP and GLP-1 receptor agonist, offering a unique mechanism of action for advanced metabolic research. This long-acting synthetic peptide is structurally engineered to mimic endogenous incretin hormones, providing insight into glucose metabolism, insulin signaling, appetite regulation, and weight modulation.
Key Research Attributes:
Dual Incretin Activation: Simultaneously targets GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) pathways, offering synergistic metabolic effects.
Metabolic Modulation: Investigated for its impact on glucose homeostasis, insulin sensitivity, and energy intake regulation.
Extended Duration: Engineered for a prolonged half-life (~5 days), enabling sustained receptor engagement in long-term studies.
High Purity: ≥98% purity, lyophilized peptide, suitable for reconstitution in sterile bacteriostatic water.
Potential Research Applications:
Mechanistic studies on appetite suppression and body weight reduction
Investigating pathways of postprandial glucose regulation
Preclinical modeling of obesity, Type 2 diabetes, and metabolic syndrome
Combination therapy exploration alongside insulin sensitizers and other incretin mimetics
Product Specifications:
Content: 5mg lyophilized Tirzepatide peptide
Form: Sterile, white/off-white powder
Storage: -20°C recommended for long-term stability
Solubility: Reconstitutes in sterile water or suitable buffer for in vitro use
Disclaimer: This product is supplied strictly for research purposes only. Not intended for diagnostic, therapeutic, or human use. Buyer assumes all responsibility for proper handling and use in accordance with local regulations.
